Our health care system needs to do a better job of diagnosing and supporting people with cannabis-related diseases,” a ...

More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...